health canada approves eurofins cdmo alphora inc s cannabis drug license for synthetic phytocannabinoids 249174

Health Canada Approves Eurofins CDMO Alphora Inc.’s Cannabis Drug License for Synthetic Phytocannabinoids

 

LUXEMBOURG, October 11, 2023–(BUSINESS WIRE)–Eurofins CDMO Alphora Inc. announces that it has received its Health Canada Cannabis Drug License issued within the Cannabis Act and Cannabis Regulations for its Oakville, Ontario operations in September 2023. This compliments the Institutional Research License obtained through Health Canada in June 2021 for its Mississauga development site and a Standard Processing 

​ LUXEMBOURG, October 11, 2023–(BUSINESS WIRE)–Eurofins CDMO Alphora Inc. announces that it has received its Health Canada Cannabis Drug License issued within the Cannabis Act and Cannabis Regulations for its Oakville, Ontario operations in September 2023. This compliments the Institutional Research License obtained through Health Canada in June 2021 for its Mississauga development site and a Standard Processing […] 

Read More 

Cannabis Law Report 

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.